Thursday, January 3, 2013

• CYTRX CORP Files SEC form 8-K, Change in Directors or Principal OfficersEDGAR Online (Thu, Jan 3)
• CytRx Promotes Dr. Daniel Levitt to Executive Vice PresidentBusiness Wire (Thu, Jan 3)

Wednesday, January 2, 2013

• CytRx to Present at the Biotech Showcase 2013 ConferenceBusiness Wire (Wed, Jan 2)

Friday, December 14, 2012

• Zacks #1 Rank Additions for FridayZacks (Fri, Dec 14)

Wednesday, December 12, 2012

• Zacks #1 Rank Additions for WednesdayZacks (Wed, Dec 12)

Tuesday, December 11, 2012

• CYTRX CORP Files SEC form 8-K, Change in Directors or Principal OfficersEDGAR Online (Tue, Dec 11)

Tuesday, December 4, 2012

• DSW Initiated at Outperform and 3 Initiated Stocks to Trackat Wall St. Cheat Sheet (Tue, Dec 4)

Thursday, November 29, 2012

• Zacks #1 Rank Additions for ThursdayZacks (Thu, Nov 29)

Monday, November 26, 2012

• FDA on Pace to Approve More New Drugs in 2012 Than the 30 Approved in 2011Marketwired (Mon, Nov 26)

Tuesday, November 20, 2012

• Zacks #1 Rank Additions for TuesdayZacks (Tue, Nov 20)

Thursday, November 15, 2012

• CytRx’s Aldoxorubicin Clinical Data Presented at Connective Tissue Oncology Society (CTOS) 7th Annual Meeting in Prague, Czech RepublicBusiness Wire (Thu, Nov 15)

Friday, November 9, 2012

• CytRx says had positive meeting with FDA to discuss potential Phase 3 trialtheflyonthewall.com (Fri, Nov 9)
• CYTRX CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and ExhibitsEDGAR Online (Fri, Nov 9)
• CytRx Reports Third Quarter 2012 Financial ResultsBusiness Wire (Fri, Nov 9)

Wednesday, October 24, 2012

• 5 Stocks With Big Insider Buyingat TheStreet (Wed, Oct 24)
• The Winner Among 45 Micro-Cap Biotech Companies Competing In Self-Beliefat Seeking Alpha (Wed, Oct 24)

Monday, October 22, 2012

• 5 Healthcare Companies With Insider Buying During October 2012 - Part IIat Seeking Alpha (Mon, Oct 22)
• Developers of Drugs for Deadly or Debilitating Diseases Could See Faster FDA PathwayMarketwired (Mon, Oct 22)

Friday, October 19, 2012

• Top Insider Trades: Berkshire Continues Buying DaVitaat Minyanville (Fri, Oct 19)
• CYTRX CORP Files SEC form 8-K, Entry into a Material Definitive Agreement, Other EventsEDGAR Online (Fri, Oct 19)

Thursday, October 18, 2012

• Thursday Sector Laggards: Paper & Forest Products, Biotechnology Stocksat Forbes (Thu, Oct 18)

Monday, October 1, 2012

• CytRx presents Aldoxorubicin clinical data at ESMO 2012 Congresstheflyonthewall.com (Mon, Oct 1)

Thursday, August 9, 2012

• CYTRX CORP Files SEC form 10-Q, Quarterly ReportEDGAR Online (Thu, Aug 9)

Tuesday, August 7, 2012

• CytRx announces favorable results for clinical trial for aldoxorubicintheflyonthewall.com (Tue, Aug 7)

Wednesday, July 25, 2012

• CytRx initiates Phase 1b trial with combination Aldoxorubicin, Doxorubicinat theflyonthewall.com (Wed, Jul 25)

Add CYTR News to My Yahoo!